Annual Accounts Receivable
$34.26 M
+$1.21 M+3.65%
December 31, 2021
Summary
- As of February 12, 2025, AMYT annual accounts receivable is $34.26 million, with the most recent change of +$1.21 million (+3.65%) on December 31, 2021.
- During the last 3 years, AMYT annual accounts receivable has risen by +$30.69 million (+859.21%).
Performance
AMYT Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Accounts Receivable
$37.60 M
-$125.00 K-0.33%
September 30, 2022
Summary
- As of February 12, 2025, AMYT quarterly accounts receivable is $37.60 million, with the most recent change of -$125.00 thousand (-0.33%) on September 30, 2022.
- Over the past year, AMYT quarterly accounts receivable has increased by +$146.00 thousand (+0.39%).
Performance
AMYT Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
AMYT Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +3.6% | +0.4% |
| 3 y3 years | +859.2% | - |
| 5 y5 years | +875.1% | +970.1% |
AMYT Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | at low | -0.3% | -14.2% |
| 5 y | 5-year | at high | -16.5% | -0.3% | -23.9% |
| alltime | all time | at high | -97.4% | -0.3% | -99.8% |
Amryt Pharma Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $37.60 M(-0.3%) |
| Jun 2022 | - | $37.73 M(+16.9%) |
| Mar 2022 | - | $32.27 M(-5.8%) |
| Dec 2021 | $34.26 M(+3.6%) | $34.26 M(-8.5%) |
| Sep 2021 | - | $37.46 M(+2.3%) |
| Jun 2021 | - | $36.63 M(-1.6%) |
| Mar 2021 | - | $37.22 M(+12.6%) |
| Dec 2020 | $33.06 M(+15.6%) | $33.06 M(+2.0%) |
| Sep 2020 | - | $32.40 M(-8.7%) |
| Jun 2020 | - | $35.51 M(+10.0%) |
| Mar 2020 | - | $32.28 M(+12.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2019 | $28.61 M(+700.9%) | $28.61 M(+326.7%) |
| Jun 2019 | - | $6.70 M(+87.7%) |
| Dec 2018 | $3.57 M(+1.7%) | $3.57 M(-31.9%) |
| Jun 2018 | - | $5.25 M(+49.3%) |
| Dec 2017 | $3.51 M(+295.9%) | $3.51 M(-37.5%) |
| Jun 2017 | - | $5.62 M(+533.7%) |
| Dec 2016 | $887.60 K | $887.60 K(+46.7%) |
| Jun 2016 | - | $605.10 K(+943.3%) |
| Sep 2015 | - | $58.00 K(-60.8%) |
| Sep 2014 | - | $148.00 K(+37.0%) |
| Sep 2013 | - | $108.00 K |
FAQ
- What is Amryt Pharma annual accounts receivable?
- What is the all time high annual accounts receivable for Amryt Pharma?
- What is Amryt Pharma annual accounts receivable year-on-year change?
- What is Amryt Pharma quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Amryt Pharma?
- What is Amryt Pharma quarterly accounts receivable year-on-year change?
What is Amryt Pharma annual accounts receivable?
The current annual accounts receivable of AMYT is $34.26 M
What is the all time high annual accounts receivable for Amryt Pharma?
Amryt Pharma all-time high annual accounts receivable is $34.26 M
What is Amryt Pharma annual accounts receivable year-on-year change?
Over the past year, AMYT annual accounts receivable has changed by +$1.21 M (+3.65%)
What is Amryt Pharma quarterly accounts receivable?
The current quarterly accounts receivable of AMYT is $37.60 M
What is the all time high quarterly accounts receivable for Amryt Pharma?
Amryt Pharma all-time high quarterly accounts receivable is $37.73 M
What is Amryt Pharma quarterly accounts receivable year-on-year change?
Over the past year, AMYT quarterly accounts receivable has changed by +$146.00 K (+0.39%)